Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Virology|February 15, 2018
Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis BAleksei Suslov, Stefan Wieland, Stephan MenneViruses|November 11, 2022
Studying Hepatitis Virus-Host Interactions in Patient Liver BiopsiesAleksei Suslov, Markus H Heim, Stefan WielandEMBO Molecular Medicine|April 1, 2017
Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liverTujana Boldanova, Aleksei Suslov, Markus H Heim, et al.Gastroenterology|February 7, 2018
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human LiverAleksei Suslov, Tujana Boldanova, Xueya Wang, et al.Journal of Hepatology|November 14, 2020
Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activityAleksei Suslov, Marie-Anne Meier, Sylvia Ketterer, et al.Journal of Hepatology|May 18, 2021
Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral loadMarie-Anne Meier, Diego Calabrese, Aleksei Suslov, et al.JHEP Reports : Innovation in Hepatology|May 30, 2026
Hepatitis C Virus Can Induce Gene Expression Changes Associated with HepatocarcinogenesisTuyana Boldanova, Fredrik Trulsson, Fahim Ebrahimi, et al.Cell Reports. Medicine|November 29, 2021
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolizationTuyana Boldanova, Geoffrey Fucile, Jan Vosshenrich, et al.Life Science Alliance|November 7, 2020
Interferon lambda 4 can directly activate human CD19+ B cells and CD8+ T cellsMairene Coto-Llerena, Marco Lepore, Julian Spagnuolo, et al.Nature Communications|August 13, 2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responsesQian Chen, Mairene Coto-Llerena, Aleksei Suslov, et al.Pageof 2